The Genetic Landscape of the Childhood Cancer Medulloblastoma

D. Williams Parsons(Howard Hughes Medical Institute), Meng Li(Howard Hughes Medical Institute), Xiaosong Zhang(Howard Hughes Medical Institute), Siân Jones(Howard Hughes Medical Institute), Rebecca Leary(Howard Hughes Medical Institute), Jimmy Lin(Howard Hughes Medical Institute), Simina M. Boca(Johns Hopkins University), Hannah Carter(Johns Hopkins University), Josue Samayoa(Johns Hopkins University), Chetan Bettegowda(Howard Hughes Medical Institute), Gary L. Gallia(Johns Hopkins University), George I. Jallo(Johns Hopkins University), Zev A. Binder(Johns Hopkins University), Yuri Nikolsky(St. Joseph Medical Center), James Hartigan(Beckman Coulter Foundation), Doug Smith(Beckman Coulter Foundation), Daniela S. Gerhard(Department of Health and Human Services), Daniel W. Fults(University of Utah), Scott R. VandenBerg(University of San Diego), Mitchel S. Berger(University of California, San Francisco), Suely Kazue Nagahashi Marie(Universidade de São Paulo), Sueli Mieko Oba‐Shinjo(Universidade de São Paulo), Carlos Clara(Hospital de Câncer de Barretos), Peter C. Phillips∥(Children's Hospital of Philadelphia), Jane E. Minturn(Children's Hospital of Philadelphia), Jaclyn A. Biegel(Children's Hospital of Philadelphia), Alexander R. Judkins(Children's Hospital of Philadelphia), Adam Resnick(Children's Hospital of Philadelphia), Phillip B. Storm(Children's Hospital of Philadelphia), Tom Curran(Children's Hospital of Philadelphia), Yiping He(Pediatric Brain Tumor Foundation), B. Ahmed Rasheed(Pediatric Brain Tumor Foundation), Henry S. Friedman(Pediatric Brain Tumor Foundation), Stephen T. Keir(Pediatric Brain Tumor Foundation), Roger E. McLendon(Pediatric Brain Tumor Foundation), Paul A. Northcott(Hospital for Sick Children), Michael D. Taylor(Hospital for Sick Children), Peter C. Burger(Johns Hopkins University), Gregory J. Riggins(Howard Hughes Medical Institute), Rachel Karchin(Johns Hopkins University), Giovanni Parmigiani(Dana-Farber Cancer Institute), Darell D. Bigner(Pediatric Brain Tumor Foundation), Hai Yan(Pediatric Brain Tumor Foundation), Nick Papadopoulos(Howard Hughes Medical Institute), Bert Vogelstein(Howard Hughes Medical Institute), Kenneth W. Kinzler(Howard Hughes Medical Institute), Victor E. Velculescu(Howard Hughes Medical Institute)
Science
December 16, 2010
Cited by 719

Abstract

Medulloblastoma (MB) is the most common malignant brain tumor of children. To identify the genetic alterations in this tumor type, we searched for copy number alterations using high-density microarrays and sequenced all known protein-coding genes and microRNA genes using Sanger sequencing in a set of 22 MBs. We found that, on average, each tumor had 11 gene alterations, fewer by a factor of 5 to 10 than in the adult solid tumors that have been sequenced to date. In addition to alterations in the Hedgehog and Wnt pathways, our analysis led to the discovery of genes not previously known to be altered in MBs. Most notably, inactivating mutations of the histone-lysine N-methyltransferase genes MLL2 or MLL3 were identified in 16% of MB patients. These results demonstrate key differences between the genetic landscapes of adult and childhood cancers, highlight dysregulation of developmental pathways as an important mechanism underlying MBs, and identify a role for a specific type of histone methylation in human tumorigenesis.


Related Papers

No related papers found

Powered by citation graph analysis